Brief: Synact Pharma Appoints Jeppe Øvlesen As CEO
March 20 (Reuters) - SynAct Pharma AB SYNACT.ST :
* SYNACT PHARMA APPOINTS JEPPE ØVLESEN CEO
* JEPPE ØVLESEN WAS APPOINTED AS NEW CEO SUCCEEDING TORBJØRN
BJERKE EFFECTIVE IMMEDIATELY DUE TO A DISAGREEMENT OVER STRATEGY
* FROM 2015 TO 2023 ØVLESEN WAS CEO OF SYNACT PHARMA
Source text for Eikon: ID:nMFN4BH20W
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026